Association of extracellular superoxide dismutase gene with cerebral infarction in women: A haplotype-based case-control study

Hereditas

Volumn 145, Issue 6, 2008, Pages 283-292

  Naganuma, Takahiro ^a,b   Nakayama, Tomohiro ^a   Sato, Naoyuki ^a   Fu, Zhenyan ^a,c   Soma, Masayoshi ^a   Aoi, Noriko ^a   Hinohara, Shigeaki ^d   Doba, Nobutaka ^d   Usami, Ron ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c XINJIANG MEDICAL UNIVERSITY   (China)

^d Life Planning Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASE-CONTROL STUDIES; CEREBRAL INFARCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; SUPEROXIDE DISMUTASE;

MUS;

EID: 59849126575     PISSN: 00180661     EISSN: 16015223     Source Type: Journal    
DOI: 10.1111/j.1601-5223.2008.02086.x     Document Type: Article

References (39)

1. Afonso V., Champy R., Mitrovic D. et al., (2007). Reactive oxygen species and superoxide dismutases: Role in joint diseases. Joint Bone Spine 74: 324-329.
2. Akishita M., (2006). Gender-specific medicine and angiology. J. Jpn Coll. Angiol. 46: 137-141.
3. Campo S., Sardo A. M., Campo G. M. et al., (2005). Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population. Mutat. Res. 578: 143-148.
4. Cha M. H., Kim K. S., Suh D. et al., (2007). Effects of genetic polymorphism of uncoupling protein 2 on body fat and calorie restriction-induced changes. Hereditas 144: 222-227.
5. Chu Y., Alwahdani A., Iida S. et al., (2005). Vascular effects of the human extracellular superoxide dimustase R213G variant. Circulation 112: 1047-1053.
6. Demechenko I. T., Oury T. D., Crapo J. D. et al., (2002). Regulation of the brain's vascular responses to oxygen. Circ. Res. 91: 1031-1037.
7. Dominiczak A. F., Negrin D. C., Clark J. S. et al., (2000). Genes and hypertension from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 35: 164-172.
8. Fattman C. L., Schaefer L. M. and Oury T. D., (2003). Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35: 236-256.
9. Folz R. J. and Crapo J. D., (1994). Extracellular superoxide dismutase (SOD3) tissue-specific expression, genomic characterization and computer-assisted sequence analysis of the human EC SOD gene. Genomics 22: 162-171.
10. Folz R. J., Guan J., Seldin M. F. et al., (1997). Mouse extracellular superoxide dismutase: Primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am. J. Respir. Cell Mol. Biol. 17: 393-403.
11. Fukui S., Nawashiro H., Ookawara T, Suzuki K. et al., (2003). Extracellular superoxide dismutase following cerebral ischemia in mice. Acta Neurochir. Suppl. 86: 83-85.
12. Gongora M. C., Qin Z., Laude K. et al., (2006). Role of extracellular superoxide dismutase in hypertension. Hypertension 48: 473-481.
13. Haketa A., Soma M., Nakayama T. et al., (2004). Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension. J. Hypertens. 22: 1903-1907.
14. Hinohara S. and Doba N., (2005). The future profile of health promotion and disease prevention in Japan: Based on the study of seniors over age 75. Methods Inf. Med. 44: 342-347.
15. Kiyohara Y., Kato I., Iwamoto H. et al., (1995). The impact of alcohol and hypertension on stroke incidence in a general Japanese population. The Hisayama study. Stroke 26: 368-372.
16. Kubo M., Hata J., Ninomiya T. et al., (2007). A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat. Genet. 39: 212-217.
17. Landis G. N. and Tower J., (2005). Superoxide dismutase evolution and life span regulation. Mech. Ageing. Dev. 126: 365-379.
18. Livak K. J., Marmaro J. and Todd J. A., (1995). Towards fully automated genome-wide polymorphism screening. Nat. Genet. 9: 341-342.
19. Ma L., Xue Y., Liu Y. et al., (2005). Polymorphism study of seven SNPs at ADH genes in 15 Chinese populations. Hereditas 142: 103-111.
20. Moorthy K., Sharma D., Basir S. F. et al., (2005). Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Exp. Gerontol. 40: 295-302.
21. Morita A., Nakayama T. and Soma M., (2006). Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am. J. Hypertens. 19: 593-600.
22. Morris R. W. and Kaplan N. L., (2002). On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet. Epidemiol. 23: 221-233.
23. Nagura J., Suzuki K., Hayashi M. et al., (2005). Stroke subtypes and lesion sites in Akita, Japan. J. Stroke Cerebrovasc. Dis. 14: 1-7.
24. Nakayama T., Soma M., Rehemudula D. et al., (2000). Association of 5′ upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am. J. Hypertens. 13: 1263-1267.
25. Ozaki K., Ohnishi Y., Iida A. et al., (2002). Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32: 650-654.
26. Parra-Rojas I., Ruíz-Madrigal B., Martínez-López E. et al., (2006). Influence of the -308 TNF-alpha and -174 IL-6 polymorphisms on lipid profile in Mexican subjects. Hereditas 143: 167-172.
27. Sato M., Nakayama T., Soma M. et al., (2007). Association between prostaglandin E2 receptor gene and essential hypertension. Prostaglandins Leukot. Essent. Fatty Acids 77: 15-20.
28. Seno H., Satoh K., Tsuji S. et al., (2007). Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: Comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J. Gastroenterol. Hepatol. 22: 729-737.
29. Sheng H., Brady T. C., Pearlstein R. D. et al., (1999). Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci. Lett. 267: 13-16.
30. Son M., Cloyd C. D., Rothstein J. D. et al., (2003). Aggregate formation in Cu,Zn superoxide dismutase-related proteins. J. Biol. Chem. 278: 14331-14336.
31. Strålin P., Karlsson K., Johansson B. O. et al., (1995). The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler. Thromb. Vasc. Biol. 15: 2032-2036.
32. Ueda K., Omae T., Hasuo Y. et al., (1988). Prognosis and outcome of elderly hypertensives in a Japanese community: Results from a long-term prospective study. J Hypertens 6: 991-997.
33. Um J.-Y., Joo J.-C., Kim K.-Y. et al., (2003). Angiotensin converting enzyme gene polymorphism and traditional Sasang classification in Koreans with cerebral infarction. Hereditas 138: 166-171.
34. Welch W. J., Blau J., Xie H. et al., (2005). Angiotensin-induced defects in renal oxygenation: Role of oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 288: H22-H28.
35. Welch W. J., Chabrashvili T., Solis G. et al., (2006). Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 48: 934-941.
36. Yamada Y., (2007). Genetic epidemiology and personalized prevention of stroke. Jpn J. Stroke 29: 715-720.
37. Zhan C. and Yang J., (2006). Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol. Res. 53: 303-309.
38. Zhang K., Calabrese P., Nordborg M. et al., (2002). Haplotype block structure and its applications to association studies: Power and study designs. Am. J. Hum. Genet. 71: 1386-1394.
39. Zhou L., Xiang W., Potts J. et al., (2006). Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic. Biol. Med. 41: 1384-1391.